Sentences with phrase «how effective the vaccine»

Efficacy is the measure of how effective a vaccine is at protecting the overall population.

However, it won't be clear for decades how effective the vaccines are in preventing cervical cancer.

Thus, it unknown how effective the vaccine will continue to be in future years unless it is updated like the human flu vaccine.

There is debate as to how effective this vaccine is.

Not exact matches

Its effectiveness depends on your baby's overall health (it's more effective in healthy children) and how well the vaccine matches the virus that's currently circulating.

Given questions about how long the vaccine is effective for, she questioned the efficacy of giving shots to girls as young as 11 years old in parts of the world (such as the U.S.) where women regularly undergo safety Pap screening repeatedly over their lifetimes, saying that the chances of their contracting cervical cancer may be less than the «small» risks associated with the vaccine.

Health officials don't know how long it would take to develop an effective vaccine, but say the best way to prevent it is by wearing long sleeves and insect repellent.

«Understanding the fundamental biology of how our immune system works will lead to the development of more effective drugs and vaccines,» said Kanneganti, corresponding author on the paper.

Researchers have new insights into how protective antibodies attack dengue viruses, which could lead to more effective dengue fever vaccines and drug therapies.

The vaccine was most effective against H3N2, increasing antibody titers (a measure how much antibody is produced after vaccination) fourfold in more than 81 percent of who received it, according to the company.

Many individual studies have looked at how effective the available vaccines were at preventing illness and hospitalisation caused by the pandemic influenza strain but up until now no - one has summarised all the available data.

They also confirmed prior findings that fear appeals are effective when they describe how to avoid the threat (e.g., get the vaccine, use a condom).

But no one knew how effective the current vaccine was.

«Nevertheless,» they state, «the model provides a useful perspective on how vaccine properties and strategic choices affect the relative size and severity of projected epidemics,» and conclude that, «a vaccine like the Sanofi - Pasteur candidate can be an effective tool for reducing the dengue burden, although a vaccine with waning efficacy would require a booster program.»

The researchers are now looking at how ICOS signals can be altered to diminish autoimmune disorders and augmented for more effective vaccine development, and are beginning research on how ICOS signaling may benefit Chimeric Antigen Receptor - T cell (CAR - T) therapies, which involves engineering of patient's own immune cells to recognize and attack their cancers.

Understanding how to elicit memory B cells, along with plasmablasts, is critical for designing effective vaccines.

The work and other similar, recent studies could also help «redefine» how vaccines are developed to make them more effective and less likely to have side effects, says Wayne Koff, the chief scientific officer at the International AIDS Vaccine Initiative in New York City, who was not involved with the research.

The standard smallpox vaccine, a virus called vaccinia, is amazingly effective, which explains how the disease was eradicated in the late 1970s.

This kind of research — figuring out which of the many HIV strains are affecting local people and how they are transmitted — is essential for designing an effective vaccine.

In this study the researchers tested how effective the long - term protection of the vaccine was.

Understanding how malaria invades the cells could lead to a more effective vaccine.

This understanding of how HIV - 1's «invisibility cloak» works could lead to the development of effective vaccines against HIV - 1.

Dr. Pontiano Kaleebu, Chairman Africa AIDS Vaccine Program and Acting Director of Uganda Virus Research Institute, delivered a strong keynote address that reiterated the importance of an HIV vaccine, what it will take to develop an effective vaccine and how community members can help with the international Vaccine Program and Acting Director of Uganda Virus Research Institute, delivered a strong keynote address that reiterated the importance of an HIV vaccine, what it will take to develop an effective vaccine and how community members can help with the international vaccine, what it will take to develop an effective vaccine and how community members can help with the international vaccine and how community members can help with the international effort.

In the new issue of IAVI Report we wrote about how researchers at the AIDS Vaccine 2010 conference in Atlanta discussed the limited window of opportunity for conducting clinical trials to test partially effective HIV prevention strategies, including HIV vaccine candidates and oral or topical antiretroviral pre-exposure prophylaxis (PrEP), in combiVaccine 2010 conference in Atlanta discussed the limited window of opportunity for conducting clinical trials to test partially effective HIV prevention strategies, including HIV vaccine candidates and oral or topical antiretroviral pre-exposure prophylaxis (PrEP), in combivaccine candidates and oral or topical antiretroviral pre-exposure prophylaxis (PrEP), in combination.

To address this growing problem, NIAID is funding and conducting research on many aspects of antimicrobial (drug) resistance, including basic research on how microbes develop resistance, development of new and faster diagnostics, and clinical trials designed to find new vaccines and treatments effective against drug - resistant microbes.

ImmuneProfiler ™: Watch how HuProt is used in rapid, cost - effective biomarker discovery in disease diagnosis, prognosis and vaccine development.

This HIV Vaccine Awareness Day, we reflect upon how much we've learned in the quest for an effective vVaccine Awareness Day, we reflect upon how much we've learned in the quest for an effective vaccinevaccine.

That is what researchers usually say when asked how much longer it will take to develop a safe and effective HIV vaccine.

In some pets it may last longer, but there is no way to predict exactly how long a vaccine will be effective in a particular animal.

In fact, there has been little research to determine how long most of the vaccines we give our pets are effective at preventing disease.

Several factors contribute to effective immunization: the patient's age, health status, the type of vaccine and how often it is given, and others.

We do not carry the FIV or FIP vaccines, because there is not enough data showing how effective they are and any vaccine side effects.

Which vaccine and what has been studied in lab trials determines how often a vaccine needs to be boostered or how often it needs to be repeated in an adult animal to be effective.